Clariane stock breaks its one-year low and falls back to €3.15
The group of medicalized retirement homes and home care services extends its decline in mid-morning trading. The stock is trading below its three moving averages, at the low point of its recent trading sessions, while the Paris market is also declining.
Clariane falls 3.49% to €3.15 and drops below the €3.23 support level, which corresponds to the low of the last 250 trading sessions. This level, held until now, becomes a resistance point. The decline amplifies the stock's fall, which loses 20.2% over one month and 25.5% over one year.
The RSI at 29 is in oversold territory, and the price is below its 20-day moving average (7.5% gap), its 50-day moving average and its 200-day moving average, the latter being 19.1% above. The stock ranks among the biggest declines in the SBF 120, which is down 1.42% in the session. Emeis, a comparable value in the sector, is down 3.23% and showing a loss of 19.9% over one month, a performance close to that of Clariane.
A tense Paris session due to debt, ahead of the revenue figure on October 28
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The CAC 40 falls 1.45% in a market penalized by tensions in French government debt. The 10-year OAT stood at 4.99% according to the Banque de France's survey dated October 21, at the highest level of the series since 2004, with a spread of 1.58 percentage points against the Bund. Clariane has already fallen more than 5.9% over the week.
On the company side, the court retained this week the offer from Clariane University to take over seven training institutes from Croix-Saint-Simon, comprising 800 students, an operation that expands the group's initial training offering. During the first half 2026 results published on July 29, the company was targeting an improvement in its EBITDA margin of 100 to 150 basis points by the end of 2026, while citing among its risks the inflationary pressure on costs. Third quarter 2026 revenue is expected on October 28.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 2 699 millions d'euros
Quarterly revenue: 2 699 millions d'euros
Revenue growth: 1,6 %
EBITDA: 524 millions d'euros
EBITDA margin: 10,4 %
Net income: -47,5 millions d'euros
Free cash flow: 20 millions d'euros
3 020 millions d'euros
Guidance from the release
Le Groupe s'appuiera principalement sur la poursuite de l'amélioration de la performance opérationnelle et le maintien d'une stricte discipline d'investissements
Risks mentioned
Environnement géopolitique complexe affectant les opérations de refinancement
Exposition aux épisodes climatiques frappant durement certains territoires en Europe
Pression inflationniste continue sur les coûts opérationnels malgré les gains tarifaires
Opportunities identified
Amélioration de la marge EBITDA de 100-150 points de base d'ici fin 2026
Croissance des volumes d'activité portée par l'augmentation progressive des taux d'occupation
Refinancement réussi de €1 063m renforçant la flexibilité financière et réduisant le coût de la dette
Outlook / guidance
Expected revenue: 5 522 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.